Effects of Framing on Medication Beliefs, Intentions to Take Medication, Adherence, and Asthma Control

Asthma Clinical Trial

Official title:

Examining the Effect of Message Framing on Medication Beliefs, Intentions to Take Medications, Adherence to Medication, and Asthma Control Among College Students

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06033313
• Other study ID #: 19-221
• Status: Completed
• Phase: N/A
• Start date: October 1, 2019
• Est. completion date: November 30, 2019

Study information

• Verified date: September 2023
• Source: Auburn University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to examine the effects of framed mobile messages on young adults' beliefs about their daily Inhaled Corticosteroids (ICS), intentions to take their ICS, adherence, and asthma control. College students (18-29 years) who owned a mobile phone and had a diagnosis of asthma with a prescription for an ICS will be recruited. Participants will be randomized to receive either gain- or loss-framed mobile messages three times per week for eight weeks. Outcomes including beliefs, intentions, adherence, and asthma control will be assessed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 43
• Est. completion date: November 30, 2019
• Est. primary completion date: November 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 29 Years

Eligibility

Inclusion Criteria:

• A diagnosis of asthma
• A prescription for an inhaled corticosteroid
• Enrolled in college
• Between 18-29 years of age
• Owns a mobile phone

Exclusion Criteria:

• Cannot read in english

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• Negatively Framed text messages
Negatively Framed text messages delivered to participants three times per week for 8 weeks.
• Positively Framed text messages
Positively Framed text messages delivered to participants three times per week for 8 weeks.

Locations

Country	Name	City	State
United States	Auburn University	Auburn	Alabama

Sponsors (1)

Lead Sponsor	Collaborator
Auburn University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in Asthma control	Asthma control as measured by the Asthma Control Test (minimum value=5, maximum value= 25) Questionnaire (scores of 20 and above indicate asthma control)	Data collection at baseline, week 4, and week 8
Secondary	Changes in Medication Beliefs	Medication Beliefs as measured by the Beliefs about Medicines Questionnaire-Specific (This scale has two sub-scales : necessity (20- points) and concerns (20 points). A difference of necessity and concern scores shows the level of perceived necessity for the medication. Higher scores indicate higher perceived necessity for the medication.	Data collection at baseline and week 8
Secondary	Intentions to take medication as prescribed	Intentions to take inhaled corticosteroids as prescribed as measured by an intentions scale (minimum score = 3, maximum score = 15; higher scores indicate greater intentions; the scale was tested in the study)	Data collection at baseline and week 8
Secondary	Changes in Medication adherence	Adherence to a daily dose of inhaled corticosteroid as measured by the Medication Adherence Report Scale for Asthma (MARS-A) (Minimum score = 10, maximum score = 50, higher scores indicate greater adherence)	Data collection at baseline, week 4, and week 8